NASDAQ:NVDQ - Novadaq Technologies Stock Price, Forecast & News Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Novadaq Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume797,205 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email NOVADAQ Technologies Inc. is a medical device company. The Company primarily develops, manufactures and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed. The Company's SPY fluorescence imaging technology platform (SPY Fluorescence Imaging) provides clinically relevant anatomic and physiologic images of blood flow in vessels and micro-vessels during a range of surgical and outpatient procedures performed in the operating room or clinic. The SPY Fluorescence Imaging platform can be used to develop imaging devices specifically designed to meet the needs of different surgeons and other healthcare providers and the specialty procedures they perform. SPY images enable physicians treating life-threatening illnesses, such as breast, head and neck, colon, complex hernias, diabetes and certain cardiovascular diseases.Read More Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryN/A SectorN/A Current SymbolNASDAQ:NVDQ Previous Symbol CUSIPN/A CIK1173293 Webhttp://novadaq.com/ Phone+1-905-6293822Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Receive NVDQ News and Ratings via Email Sign-up to receive the latest news and ratings for NVDQ and its competitors with MarketBeat's FREE daily newsletter. Novadaq Technologies (NASDAQ:NVDQ) Frequently Asked Questions How were Novadaq Technologies' earnings last quarter? Novadaq Technologies Inc. (NASDAQ:NVDQ) announced its earnings results on Wednesday, May, 3rd. The medical research company reported ($0.24) EPS for the quarter, missing analysts' consensus estimates of ($0.21) by $0.03. The medical research company earned $21.08 million during the quarter, compared to analysts' expectations of $20.12 million. View Novadaq Technologies' earnings history. Has Novadaq Technologies been receiving favorable news coverage? Press coverage about NVDQ stock has trended somewhat positive recently, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Novadaq Technologies earned a media sentiment score of 0.8 on InfoTrie's scale. They also assigned media stories about the medical research company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the stock's share price in the near future. View the latest news aboutNovadaq Technologies. What other stocks do shareholders of Novadaq Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other Novadaq Technologies investors own include Hawkins (HWKN), CA (CA), BlackRock (BLK), Athabasca Oil (ATH), Chipotle Mexican Grill (CMG), Endologix (ELGX), NN (NNBR), Bank Of The Ozarks (OZRK), Accenture (ACN) and Apollo Commercial Real Est. Finance (ARI). Who are Novadaq Technologies' key executives? Novadaq Technologies' management team includes the following people: William A. MacKinnon, Chairman of the BoardRick Mangat Ph.D., President, Chief Executive Officer, Bio & Compensation - Roger Deck, Chief Financial Officer, Bio & Compensation - Lori Swalm, Vice President of Marketing, Bio & Compensation - Derrick Guo, General Counsel, Corporate Secretary, Bio & Compensation - Anthony F. Griffiths, Lead Independent DirectorLisa N. Colleran, DirectorKaren A. Licitra, Director, Bio & Compensation - Patrice E. Merrin, Independent DirectorThomas G. Wellner, Independent Director What is Novadaq Technologies' stock symbol? Novadaq Technologies trades on the NASDAQ under the ticker symbol "NVDQ." What is Novadaq Technologies' official website? The official website for Novadaq Technologies is http://novadaq.com/. How can I contact Novadaq Technologies? Novadaq Technologies' mailing address is 5090 Explorer Dr Suite 202, MISSISSAUGA, ON L4W 4T9, Canada. The medical research company can be reached via phone at +1-905-6293822. MarketBeat Community Rating for Novadaq Technologies (NASDAQ NVDQ)Community Ranking: 2.9 out of 5 ( )Outperform Votes: 351 (Vote Outperform)Underperform Votes: 246 (Vote Underperform)Total Votes: 597MarketBeat's community ratings are surveys of what our community members think about Novadaq Technologies and other stocks. Vote "Outperform" if you believe NVDQ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NVDQ will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/28/2020 by MarketBeat.com StaffFeatured Article: Current Ratio
